Microbot Medical Strengthen its Scientific Advisory Board with the Recent Addition of Dr. Sebastian Flacke

HINGHAM, Mass., Sept. 08, 2022 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), which continues to build a reputation within the interventional radiology community for its LIBERTY^® Robotic System, today announced the newest appointment to its Scientific Advisory Board (SAB), Sebastian Flacke, M.D. The addition of this thought leader adds a key robotic pioneer, who has a history of contributing to the development and commercialization of novel medical device products.

“Dr. Flacke is a proven innovator in the robotics field and has pioneered new solutions for his patients in interventional radiology, specifically the endovascular space,” commented Harel Gadot, Chairman, CEO, and President. “We expect the addition of Dr. Flacke is further evidence that we are establishing the right scientific team to help guide Microbot through the regulatory process and transform the market with the first fully disposable endovascular robotic system that will enable access to multiple patients and users globally.”